Cargando…
Irisin: A Promising Target for Ischemia-Reperfusion Injury Therapy
Ischemia-reperfusion injury (IRI) is defined as the total combined damage that occurs during a period of ischemia and following the recovery of blood flow. Oxidative stress, mitochondrial dysfunction, and an inflammatory response are factors contributing to IRI-related damage that can each result in...
Autores principales: | Wang, Yani, Liu, Huibin, Sun, Na, Li, Jing, Peng, Xiang, Jia, Ying, Karch, Jason, Yu, Bo, Wehrens, Xander H. T., Tian, Jinwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570861/ https://www.ncbi.nlm.nih.gov/pubmed/34745418 http://dx.doi.org/10.1155/2021/5391706 |
Ejemplares similares
-
Irisin Protects Against Hind Limb Ischemia Reperfusion Injury
por: Küçük, Ayşegül, et al.
Publicado: (2021) -
Irisin Contributes to the Hepatoprotection of Dexmedetomidine during Intestinal Ischemia/Reperfusion
por: Fan, Xin, et al.
Publicado: (2019) -
Irisin ameliorates myocardial ischemia-reperfusion injury by modulating gut microbiota and intestinal permeability in rats
por: Liu, Qingqing, et al.
Publicado: (2023) -
Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm
por: Peng, Xiang, et al.
Publicado: (2021) -
Irisin Attenuates Myocardial Ischemia/Reperfusion Injury and Improves Mitochondrial Function Through AMPK Pathway in Diabetic Mice
por: Xin, Chao, et al.
Publicado: (2020)